nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—Tiaprofenic acid—Zileuton—asthma	0.302	1	CrCrCtD
Nepafenac—PTGS2—asthma	0.232	1	CbGaD
Nepafenac—PTGS1—Zileuton—asthma	0.0771	0.265	CbGbCtD
Nepafenac—PTGS1—Zafirlukast—asthma	0.0679	0.233	CbGbCtD
Nepafenac—PTGS1—Montelukast—asthma	0.0497	0.171	CbGbCtD
Nepafenac—PTGS2—Triamcinolone—asthma	0.0408	0.14	CbGbCtD
Nepafenac—PTGS2—Betamethasone—asthma	0.035	0.12	CbGbCtD
Nepafenac—PTGS2—Dexamethasone—asthma	0.0204	0.07	CbGbCtD
Nepafenac—PTGS1—Eicosanoid Synthesis—ALOX5AP—asthma	0.000763	0.0173	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PTGDR—asthma	0.000751	0.017	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—LTA4H—asthma	0.000676	0.0153	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—ALOX5—asthma	0.000649	0.0147	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—LTC4S—asthma	0.000619	0.014	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—ALOX15—asthma	0.000606	0.0138	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—ALOX5AP—asthma	0.000606	0.0138	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—LTA4H—asthma	0.000537	0.0122	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—ALOX5—asthma	0.000515	0.0117	CbGpPWpGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—asthma	0.000508	0.0115	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—asthma	0.000499	0.0113	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—HMOX1—asthma	0.000465	0.0106	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—EDNRB—asthma	0.000447	0.0102	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—ALOX5AP—asthma	0.000424	0.00964	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—ALOX15—asthma	0.000424	0.00964	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000373	0.111	CbGdCrCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—HMOX1—asthma	0.000369	0.00839	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000366	0.109	CbGdCrCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—asthma	0.000365	0.00828	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—ALOX5—asthma	0.000361	0.00819	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—EDNRB—asthma	0.000355	0.00806	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.000341	0.101	CbGdCrCtD
Nepafenac—PTGS2—Arachidonic acid metabolism—ALOX15—asthma	0.000337	0.00765	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—ALOX5AP—asthma	0.000337	0.00765	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—FN1—asthma	0.000336	0.00764	CbGpPWpGaD
Nepafenac—Diclofenac—ALOX5—asthma	0.000321	0.117	CrCbGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—asthma	0.000312	0.00709	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—asthma	0.000312	0.00709	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—asthma	0.000304	0.00691	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—asthma	0.000301	0.00683	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—asthma	0.000297	0.00673	CbGpPWpGaD
Nepafenac—PTGS2—S1P1 pathway—PDGFB—asthma	0.000296	0.00672	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—asthma	0.000289	0.00657	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—ALOX5—asthma	0.000286	0.0065	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALOX5AP—asthma	0.00027	0.00613	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—FN1—asthma	0.000267	0.00606	CbGpPWpGaD
Nepafenac—Diclofenac—CXCL8—asthma	0.000266	0.0972	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—BCL2—asthma	0.000257	0.00584	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LTB4R—asthma	0.000251	0.0057	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Beclomethasone—asthma	0.000251	0.0745	CbGdCrCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—asthma	0.000245	0.00557	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—asthma	0.000244	0.00555	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—asthma	0.000243	0.00551	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—asthma	0.000242	0.00549	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Budesonide—asthma	0.000241	0.0714	CbGdCrCtD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—asthma	0.000239	0.00542	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—asthma	0.000239	0.00542	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Flunisolide—asthma	0.000237	0.0705	CbGdCrCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—CXCL8—asthma	0.000237	0.00538	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—ARG1—asthma	0.000236	0.00536	CbGpPWpGaD
Nepafenac—Ketoprofen—CXCL8—asthma	0.000235	0.0861	CrCbGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000231	0.00525	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALOX5—asthma	0.00023	0.00521	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—asthma	0.000229	0.0052	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NQO1—asthma	0.000221	0.00503	CbGpPWpGaD
Nepafenac—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000221	0.0656	CbGdCrCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—asthma	0.000219	0.00497	CbGpPWpGaD
Nepafenac—Ketorolac—PTGS2—asthma	0.000218	0.0799	CrCbGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—asthma	0.000217	0.00493	CbGpPWpGaD
Nepafenac—PTGS2—S1P1 pathway—RHOA—asthma	0.000214	0.00487	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALOX5AP—asthma	0.000214	0.00487	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—asthma	0.000211	0.00479	CbGpPWpGaD
Nepafenac—Bromfenac—PTGS2—asthma	0.000209	0.0766	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—BCL2—asthma	0.000204	0.00464	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—asthma	0.000204	0.00463	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—asthma	0.000203	0.0046	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—asthma	0.000202	0.00459	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PLA2G4A—asthma	0.0002	0.00454	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MIF—asthma	0.000197	0.00447	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—MYB—asthma	0.000196	0.00445	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Mometasone—asthma	0.000195	0.0577	CbGdCrCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—CXCL8—asthma	0.000188	0.00427	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALOX5—asthma	0.000182	0.00414	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—asthma	0.000178	0.0651	CrCbGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—asthma	0.000175	0.00398	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—asthma	0.00017	0.00385	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1R1—asthma	0.00017	0.00385	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS2—asthma	0.000165	0.0605	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—asthma	0.000165	0.00375	CbGpPWpGaD
Nepafenac—Skin disorder—Fluticasone Propionate—asthma	0.000165	0.00131	CcSEcCtD
Nepafenac—Sinusitis—Budesonide—asthma	0.000165	0.00131	CcSEcCtD
Nepafenac—Skin disorder—Salmeterol—asthma	0.000165	0.00131	CcSEcCtD
Nepafenac—Vomiting—Nedocromil—asthma	0.000164	0.00131	CcSEcCtD
Nepafenac—Pruritus—Zafirlukast—asthma	0.000164	0.00131	CcSEcCtD
Nepafenac—Dizziness—Fluticasone furoate—asthma	0.000163	0.0013	CcSEcCtD
Nepafenac—Vomiting—Pirbuterol—asthma	0.000163	0.0013	CcSEcCtD
Nepafenac—Cataract—Dexamethasone—asthma	0.000163	0.0013	CcSEcCtD
Nepafenac—Cataract—Betamethasone—asthma	0.000163	0.0013	CcSEcCtD
Nepafenac—Hypersensitivity—Theophylline—asthma	0.000163	0.0013	CcSEcCtD
Nepafenac—Vision blurred—Flunisolide—asthma	0.000162	0.00129	CcSEcCtD
Nepafenac—Headache—Nedocromil—asthma	0.000162	0.00129	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—asthma	0.000162	0.0592	CrCbGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—asthma	0.000162	0.00368	CbGpPWpGaD
Nepafenac—Headache—Pirbuterol—asthma	0.000161	0.00128	CcSEcCtD
Nepafenac—Hypertension—Loratadine—asthma	0.000161	0.00128	CcSEcCtD
Nepafenac—Hypertension—Tiotropium—asthma	0.00016	0.00128	CcSEcCtD
Nepafenac—Nausea—Zileuton—asthma	0.00016	0.00128	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—asthma	0.000159	0.0036	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—PLA2G4A—asthma	0.000159	0.0036	CbGpPWpGaD
Nepafenac—Nausea—Indacaterol—asthma	0.000158	0.00126	CcSEcCtD
Nepafenac—Nervous system disorder—Aminophylline—asthma	0.000158	0.00126	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Loratadine—asthma	0.000157	0.00125	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—asthma	0.000157	0.00125	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—asthma	0.000157	0.00356	CbGpPWpGaD
Nepafenac—Nausea—Orciprenaline—asthma	0.000157	0.00125	CcSEcCtD
Nepafenac—Pruritus—Theophylline—asthma	0.000156	0.00124	CcSEcCtD
Nepafenac—Immune system disorder—Formoterol—asthma	0.000156	0.00124	CcSEcCtD
Nepafenac—Immune system disorder—Arformoterol—asthma	0.000156	0.00124	CcSEcCtD
Nepafenac—Diabetes mellitus—Prednisolone—asthma	0.000155	0.00123	CcSEcCtD
Nepafenac—Dry mouth—Loratadine—asthma	0.000155	0.00123	CcSEcCtD
Nepafenac—Headache—Fluticasone furoate—asthma	0.000155	0.00123	CcSEcCtD
Nepafenac—Dry mouth—Tiotropium—asthma	0.000155	0.00123	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—asthma	0.000154	0.00351	CbGpPWpGaD
Nepafenac—Nausea—Nedocromil—asthma	0.000154	0.00122	CcSEcCtD
Nepafenac—Dizziness—Zafirlukast—asthma	0.000153	0.00122	CcSEcCtD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—asthma	0.000153	0.00347	CbGpPWpGaD
Nepafenac—Nausea—Pirbuterol—asthma	0.000153	0.00121	CcSEcCtD
Nepafenac—Immune system disorder—Montelukast—asthma	0.000152	0.00121	CcSEcCtD
Nepafenac—Diabetes mellitus—Hydrocortisone—asthma	0.000151	0.00121	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Ipratropium bromide—asthma	0.000151	0.00121	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	0.000151	0.0449	CbGdCrCtD
Nepafenac—PTGS2—C-MYB transcription factor network—GATA3—asthma	0.000151	0.00343	CbGpPWpGaD
Nepafenac—Nervous system disorder—Loratadine—asthma	0.000149	0.00119	CcSEcCtD
Nepafenac—Nervous system disorder—Tiotropium—asthma	0.000149	0.00118	CcSEcCtD
Nepafenac—Hypertension—Flunisolide—asthma	0.000149	0.00118	CcSEcCtD
Nepafenac—Angiopathy—Salbutamol—asthma	0.000148	0.00117	CcSEcCtD
Nepafenac—Skin disorder—Loratadine—asthma	0.000148	0.00117	CcSEcCtD
Nepafenac—Vomiting—Zafirlukast—asthma	0.000148	0.00117	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—asthma	0.000147	0.0539	CrCbGaD
Nepafenac—Skin disorder—Tiotropium—asthma	0.000147	0.00117	CcSEcCtD
Nepafenac—Eye disorder—Budesonide—asthma	0.000147	0.00117	CcSEcCtD
Nepafenac—Immune system disorder—Salbutamol—asthma	0.000147	0.00117	CcSEcCtD
Nepafenac—Nausea—Fluticasone furoate—asthma	0.000147	0.00117	CcSEcCtD
Nepafenac—Dizziness—Beclomethasone—asthma	0.000146	0.00116	CcSEcCtD
Nepafenac—Dizziness—Theophylline—asthma	0.000146	0.00116	CcSEcCtD
Nepafenac—Headache—Zafirlukast—asthma	0.000145	0.00116	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—asthma	0.000144	0.00328	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—C5—asthma	0.000144	0.00327	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TACR1—asthma	0.000144	0.00327	CbGpPWpGaD
Nepafenac—PTGS2—Fluticasone Propionate—Flunisolide—asthma	0.000143	0.0425	CbGdCrCtD
Nepafenac—Dry eye—Betamethasone—asthma	0.000143	0.00114	CcSEcCtD
Nepafenac—Dry eye—Dexamethasone—asthma	0.000143	0.00114	CcSEcCtD
Nepafenac—Angiopathy—Budesonide—asthma	0.000143	0.00114	CcSEcCtD
Nepafenac—Diabetes mellitus—Triamcinolone—asthma	0.000143	0.00114	CcSEcCtD
Nepafenac—Immune system disorder—Budesonide—asthma	0.000142	0.00113	CcSEcCtD
Nepafenac—Diabetes mellitus—Methylprednisolone—asthma	0.000142	0.00113	CcSEcCtD
Nepafenac—Cataract—Prednisone—asthma	0.000142	0.00113	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CDK2—asthma	0.000142	0.00322	CbGpPWpGaD
Nepafenac—Hypersensitivity—Cromoglicic acid—asthma	0.000142	0.00113	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—asthma	0.000141	0.00321	CbGpPWpGaD
Nepafenac—Salsalate—PTGS2—asthma	0.000141	0.0515	CrCbGaD
Nepafenac—Vomiting—Theophylline—asthma	0.00014	0.00112	CcSEcCtD
Nepafenac—Dizziness—Ciclesonide—asthma	0.00014	0.00111	CcSEcCtD
Nepafenac—Headache—Beclomethasone—asthma	0.000138	0.0011	CcSEcCtD
Nepafenac—Headache—Theophylline—asthma	0.000138	0.0011	CcSEcCtD
Nepafenac—Nausea—Zafirlukast—asthma	0.000138	0.0011	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—CAT—asthma	0.000135	0.00306	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—asthma	0.000133	0.00302	CbGpPWpGaD
Nepafenac—Dry mouth—Mometasone—asthma	0.000133	0.00106	CcSEcCtD
Nepafenac—Headache—Ciclesonide—asthma	0.000132	0.00105	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Loratadine—asthma	0.000131	0.00104	CcSEcCtD
Nepafenac—Nausea—Beclomethasone—asthma	0.000131	0.00104	CcSEcCtD
Nepafenac—Nausea—Theophylline—asthma	0.000131	0.00104	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—asthma	0.000131	0.00297	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Tiotropium—asthma	0.000131	0.00104	CcSEcCtD
Nepafenac—Hypertension—Formoterol—asthma	0.00013	0.00103	CcSEcCtD
Nepafenac—Hypertension—Arformoterol—asthma	0.00013	0.00103	CcSEcCtD
Nepafenac—Diabetes mellitus—Dexamethasone—asthma	0.000129	0.00103	CcSEcCtD
Nepafenac—Diabetes mellitus—Betamethasone—asthma	0.000129	0.00103	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000129	0.00294	CbGpPWpGaD
Nepafenac—Vision blurred—Budesonide—asthma	0.000129	0.00103	CcSEcCtD
Nepafenac—Hypersensitivity—Ipratropium bromide—asthma	0.000129	0.00103	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—asthma	0.000128	0.00291	CbGpPWpGaD
Nepafenac—Dizziness—Cromoglicic acid—asthma	0.000127	0.00101	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—asthma	0.000127	0.00101	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Formoterol—asthma	0.000127	0.00101	CcSEcCtD
Nepafenac—Nausea—Ciclesonide—asthma	0.000126	0.000999	CcSEcCtD
Nepafenac—Hypersensitivity—Fluticasone Propionate—asthma	0.000125	0.000996	CcSEcCtD
Nepafenac—Dry mouth—Arformoterol—asthma	0.000125	0.000994	CcSEcCtD
Nepafenac—Dry mouth—Formoterol—asthma	0.000125	0.000994	CcSEcCtD
Nepafenac—Hypersensitivity—Salmeterol—asthma	0.000125	0.000993	CcSEcCtD
Nepafenac—Eye pain—Dexamethasone—asthma	0.000125	0.000992	CcSEcCtD
Nepafenac—Eye pain—Betamethasone—asthma	0.000125	0.000992	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.000124	0.000989	CcSEcCtD
Nepafenac—Pruritus—Ipratropium bromide—asthma	0.000124	0.000988	CcSEcCtD
Nepafenac—PTGS1—Biological oxidations—ALDH2—asthma	0.000123	0.00279	CbGpPWpGaD
Nepafenac—Hypertension—Salbutamol—asthma	0.000122	0.000973	CcSEcCtD
Nepafenac—Headache—Cromoglicic acid—asthma	0.00012	0.000957	CcSEcCtD
Nepafenac—Pruritus—Fluticasone Propionate—asthma	0.00012	0.000956	CcSEcCtD
Nepafenac—Nervous system disorder—Arformoterol—asthma	0.00012	0.000956	CcSEcCtD
Nepafenac—Nervous system disorder—Formoterol—asthma	0.00012	0.000956	CcSEcCtD
Nepafenac—Skin disorder—Arformoterol—asthma	0.000119	0.000946	CcSEcCtD
Nepafenac—Skin disorder—Formoterol—asthma	0.000119	0.000946	CcSEcCtD
Nepafenac—Hypersensitivity—Aminophylline—asthma	0.000119	0.000943	CcSEcCtD
Nepafenac—Hypertension—Budesonide—asthma	0.000118	0.000943	CcSEcCtD
Nepafenac—Dry mouth—Salbutamol—asthma	0.000118	0.000939	CcSEcCtD
Nepafenac—Nervous system disorder—Montelukast—asthma	0.000118	0.000936	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Mometasone—asthma	0.000117	0.0348	CbGdCrCtD
Nepafenac—PTGS1—Biological oxidations—GSTT1—asthma	0.000117	0.00265	CbGpPWpGaD
Nepafenac—Skin disorder—Montelukast—asthma	0.000116	0.000927	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—asthma	0.000116	0.0425	CrCbGaD
Nepafenac—PTGS2—Fluocinonide—Methylprednisolone—asthma	0.000116	0.0345	CbGdCrCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.000116	0.000923	CcSEcCtD
Nepafenac—Dizziness—Ipratropium bromide—asthma	0.000116	0.000923	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000115	0.00262	CbGpPWpGaD
Nepafenac—PTGS2—Fluocinonide—Dexamethasone—asthma	0.000114	0.0339	CbGdCrCtD
Nepafenac—PTGS2—Fluocinonide—Betamethasone—asthma	0.000114	0.0339	CbGdCrCtD
Nepafenac—Dry mouth—Budesonide—asthma	0.000114	0.000909	CcSEcCtD
Nepafenac—Nausea—Cromoglicic acid—asthma	0.000114	0.000908	CcSEcCtD
Nepafenac—Pruritus—Aminophylline—asthma	0.000114	0.000906	CcSEcCtD
Nepafenac—Nervous system disorder—Salbutamol—asthma	0.000113	0.000902	CcSEcCtD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—asthma	0.000113	0.00256	CbGpPWpGaD
Nepafenac—Diabetes mellitus—Prednisone—asthma	0.000113	0.000897	CcSEcCtD
Nepafenac—Skin disorder—Salbutamol—asthma	0.000112	0.000894	CcSEcCtD
Nepafenac—Dizziness—Fluticasone Propionate—asthma	0.000112	0.000894	CcSEcCtD
Nepafenac—Dizziness—Salmeterol—asthma	0.000112	0.000891	CcSEcCtD
Nepafenac—Hypersensitivity—Tiotropium—asthma	0.000112	0.000889	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Triamcinolone—asthma	0.000112	0.0332	CbGdCrCtD
Nepafenac—Vomiting—Ipratropium bromide—asthma	0.000112	0.000888	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000111	0.00253	CbGpPWpGaD
Nepafenac—Headache—Ipratropium bromide—asthma	0.00011	0.000875	CcSEcCtD
Nepafenac—Nervous system disorder—Budesonide—asthma	0.00011	0.000874	CcSEcCtD
Nepafenac—Skin disorder—Budesonide—asthma	0.000109	0.000866	CcSEcCtD
Nepafenac—Vomiting—Fluticasone Propionate—asthma	0.000108	0.000859	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—asthma	0.000108	0.0395	CrCbGaD
Nepafenac—Vomiting—Salmeterol—asthma	0.000108	0.000857	CcSEcCtD
Nepafenac—Pruritus—Tiotropium—asthma	0.000107	0.000854	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—asthma	0.000107	0.00243	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CAT—asthma	0.000107	0.00243	CbGpPWpGaD
Nepafenac—Dizziness—Aminophylline—asthma	0.000106	0.000847	CcSEcCtD
Nepafenac—Headache—Fluticasone Propionate—asthma	0.000106	0.000847	CcSEcCtD
Nepafenac—Headache—Salmeterol—asthma	0.000106	0.000844	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—asthma	0.000106	0.0024	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Formoterol—asthma	0.000106	0.000841	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Arformoterol—asthma	0.000106	0.000841	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—GSTM1—asthma	0.000105	0.00238	CbGpPWpGaD
Nepafenac—Nausea—Ipratropium bromide—asthma	0.000104	0.000829	CcSEcCtD
Nepafenac—Hypersensitivity—Flunisolide—asthma	0.000104	0.000824	CcSEcCtD
Nepafenac—Fenoprofen—ALB—asthma	0.000104	0.0379	CrCbGaD
Nepafenac—Gastrointestinal disorder—Montelukast—asthma	0.000104	0.000824	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—NOS1—asthma	0.000103	0.00233	CbGpPWpGaD
Nepafenac—Vomiting—Aminophylline—asthma	0.000102	0.000814	CcSEcCtD
Nepafenac—Nausea—Fluticasone Propionate—asthma	0.000101	0.000803	CcSEcCtD
Nepafenac—Headache—Aminophylline—asthma	0.000101	0.000802	CcSEcCtD
Nepafenac—Nausea—Salmeterol—asthma	0.000101	0.000801	CcSEcCtD
Nepafenac—Dizziness—Loratadine—asthma	0.000101	0.0008	CcSEcCtD
Nepafenac—Dizziness—Tiotropium—asthma	0.0001	0.000798	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Salbutamol—asthma	9.98e-05	0.000794	CcSEcCtD
Nepafenac—Pruritus—Flunisolide—asthma	9.95e-05	0.000792	CcSEcCtD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—asthma	9.9e-05	0.00225	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ICAM1—asthma	9.83e-05	0.00223	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Budesonide—asthma	9.67e-05	0.000769	CcSEcCtD
Nepafenac—Vomiting—Loratadine—asthma	9.66e-05	0.000769	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LTA4H—asthma	9.66e-05	0.00219	CbGpPWpGaD
Nepafenac—Vomiting—Tiotropium—asthma	9.65e-05	0.000768	CcSEcCtD
Nepafenac—Nausea—Aminophylline—asthma	9.56e-05	0.00076	CcSEcCtD
Nepafenac—Headache—Loratadine—asthma	9.52e-05	0.000758	CcSEcCtD
Nepafenac—Headache—Tiotropium—asthma	9.5e-05	0.000756	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—asthma	9.33e-05	0.00212	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL10—asthma	9.31e-05	0.00211	CbGpPWpGaD
Nepafenac—Dizziness—Flunisolide—asthma	9.3e-05	0.00074	CcSEcCtD
Nepafenac—Pruritus—Mometasone—asthma	9.23e-05	0.000734	CcSEcCtD
Nepafenac—Nausea—Loratadine—asthma	9.03e-05	0.000718	CcSEcCtD
Nepafenac—Hypersensitivity—Arformoterol—asthma	9.02e-05	0.000718	CcSEcCtD
Nepafenac—Hypersensitivity—Formoterol—asthma	9.02e-05	0.000718	CcSEcCtD
Nepafenac—Nausea—Tiotropium—asthma	9.01e-05	0.000717	CcSEcCtD
Nepafenac—Vomiting—Flunisolide—asthma	8.94e-05	0.000711	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LTC4S—asthma	8.84e-05	0.00201	CbGpPWpGaD
Nepafenac—Hypersensitivity—Montelukast—asthma	8.84e-05	0.000703	CcSEcCtD
Nepafenac—Headache—Flunisolide—asthma	8.81e-05	0.000701	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—asthma	8.8e-05	0.002	CbGpPWpGaD
Nepafenac—Oxcarbazepine—ALB—asthma	8.69e-05	0.0318	CrCbGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—asthma	8.68e-05	0.00197	CbGpPWpGaD
Nepafenac—Pruritus—Arformoterol—asthma	8.66e-05	0.000689	CcSEcCtD
Nepafenac—Pruritus—Formoterol—asthma	8.66e-05	0.000689	CcSEcCtD
Nepafenac—Eye disorder—Hydrocortisone—asthma	8.52e-05	0.000678	CcSEcCtD
Nepafenac—Hypersensitivity—Salbutamol—asthma	8.52e-05	0.000678	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—asthma	8.49e-05	0.00193	CbGpPWpGaD
Nepafenac—Pruritus—Montelukast—asthma	8.48e-05	0.000675	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—BDNF—asthma	8.37e-05	0.0019	CbGpPWpGaD
Nepafenac—Nausea—Flunisolide—asthma	8.35e-05	0.000665	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—asthma	8.29e-05	0.00188	CbGpPWpGaD
Nepafenac—Vomiting—Mometasone—asthma	8.29e-05	0.00066	CcSEcCtD
Nepafenac—Hypersensitivity—Budesonide—asthma	8.25e-05	0.000657	CcSEcCtD
Nepafenac—Immune system disorder—Hydrocortisone—asthma	8.23e-05	0.000655	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—asthma	8.21e-05	0.00186	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—asthma	8.2e-05	0.00186	CbGpPWpGaD
Nepafenac—Pruritus—Salbutamol—asthma	8.18e-05	0.000651	CcSEcCtD
Nepafenac—Headache—Mometasone—asthma	8.17e-05	0.00065	CcSEcCtD
Nepafenac—PTGS1—Biological oxidations—GSTP1—asthma	8.1e-05	0.00184	CbGpPWpGaD
Nepafenac—Dizziness—Arformoterol—asthma	8.1e-05	0.000644	CcSEcCtD
Nepafenac—Dizziness—Formoterol—asthma	8.1e-05	0.000644	CcSEcCtD
Nepafenac—Eye disorder—Methylprednisolone—asthma	8e-05	0.000637	CcSEcCtD
Nepafenac—Dizziness—Montelukast—asthma	7.93e-05	0.000631	CcSEcCtD
Nepafenac—Pruritus—Budesonide—asthma	7.92e-05	0.00063	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—ICAM1—asthma	7.8e-05	0.00177	CbGpPWpGaD
Nepafenac—Vomiting—Formoterol—asthma	7.78e-05	0.000619	CcSEcCtD
Nepafenac—Vomiting—Arformoterol—asthma	7.78e-05	0.000619	CcSEcCtD
Nepafenac—Angiopathy—Methylprednisolone—asthma	7.77e-05	0.000618	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—IL4—asthma	7.77e-05	0.00176	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—asthma	7.75e-05	0.0283	CrCbGaD
Nepafenac—Nausea—Mometasone—asthma	7.75e-05	0.000617	CcSEcCtD
Nepafenac—Immune system disorder—Methylprednisolone—asthma	7.74e-05	0.000616	CcSEcCtD
Nepafenac—Headache—Formoterol—asthma	7.67e-05	0.00061	CcSEcCtD
Nepafenac—Headache—Arformoterol—asthma	7.67e-05	0.00061	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—asthma	7.67e-05	0.00174	CbGpPWpGaD
Nepafenac—Vision blurred—Prednisolone—asthma	7.66e-05	0.000609	CcSEcCtD
Nepafenac—Dizziness—Salbutamol—asthma	7.64e-05	0.000608	CcSEcCtD
Nepafenac—Vomiting—Montelukast—asthma	7.62e-05	0.000607	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—asthma	7.54e-05	0.00171	CbGpPWpGaD
Nepafenac—Headache—Montelukast—asthma	7.51e-05	0.000598	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—IFNG—asthma	7.48e-05	0.0017	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTM1—asthma	7.44e-05	0.00169	CbGpPWpGaD
Nepafenac—Dizziness—Budesonide—asthma	7.41e-05	0.000589	CcSEcCtD
Nepafenac—Vomiting—Salbutamol—asthma	7.35e-05	0.000585	CcSEcCtD
Nepafenac—Eye disorder—Betamethasone—asthma	7.28e-05	0.000579	CcSEcCtD
Nepafenac—Eye disorder—Dexamethasone—asthma	7.28e-05	0.000579	CcSEcCtD
Nepafenac—Nausea—Arformoterol—asthma	7.27e-05	0.000579	CcSEcCtD
Nepafenac—Nausea—Formoterol—asthma	7.27e-05	0.000579	CcSEcCtD
Nepafenac—Headache—Salbutamol—asthma	7.24e-05	0.000576	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—asthma	7.17e-05	0.00163	CbGpPWpGaD
Nepafenac—Nausea—Montelukast—asthma	7.12e-05	0.000567	CcSEcCtD
Nepafenac—Vomiting—Budesonide—asthma	7.12e-05	0.000567	CcSEcCtD
Nepafenac—Angiopathy—Betamethasone—asthma	7.07e-05	0.000562	CcSEcCtD
Nepafenac—Angiopathy—Dexamethasone—asthma	7.07e-05	0.000562	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—asthma	7.04e-05	0.0016	CbGpPWpGaD
Nepafenac—Headache—Budesonide—asthma	7.02e-05	0.000558	CcSEcCtD
Nepafenac—Hypertension—Prednisolone—asthma	7.01e-05	0.000558	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	7.01e-05	0.0208	CbGdCrCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—asthma	6.98e-05	0.00159	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—asthma	6.91e-05	0.00157	CbGpPWpGaD
Nepafenac—Diclofenac—ALB—asthma	6.9e-05	0.0253	CrCbGaD
Nepafenac—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	6.9e-05	0.0205	CbGdCrCtD
Nepafenac—PTGS2—Fluticasone Propionate—Betamethasone—asthma	6.9e-05	0.0205	CbGdCrCtD
Nepafenac—Nausea—Salbutamol—asthma	6.87e-05	0.000546	CcSEcCtD
Nepafenac—Ketoprofen—PTGS2—asthma	6.86e-05	0.0251	CrCbGaD
Nepafenac—Hypertension—Hydrocortisone—asthma	6.85e-05	0.000545	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—asthma	6.78e-05	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	6.74e-05	0.02	CbGdCrCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.71e-05	0.000534	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—asthma	6.67e-05	0.00151	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDK2—asthma	6.67e-05	0.00151	CbGpPWpGaD
Nepafenac—Nausea—Budesonide—asthma	6.65e-05	0.000529	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—asthma	6.57e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—asthma	6.52e-05	0.00148	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—asthma	6.51e-05	0.00148	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—asthma	6.46e-05	0.00147	CbGpPWpGaD
Nepafenac—Hypertension—Triamcinolone—asthma	6.45e-05	0.000513	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—TLR4—asthma	6.44e-05	0.00146	CbGpPWpGaD
Nepafenac—Hypertension—Methylprednisolone—asthma	6.44e-05	0.000512	CcSEcCtD
Nepafenac—Nervous system disorder—Hydrocortisone—asthma	6.35e-05	0.000505	CcSEcCtD
Nepafenac—Eye disorder—Prednisone—asthma	6.34e-05	0.000504	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.3e-05	0.000502	CcSEcCtD
Nepafenac—Skin disorder—Hydrocortisone—asthma	6.29e-05	0.000501	CcSEcCtD
Nepafenac—Dry mouth—Triamcinolone—asthma	6.22e-05	0.000495	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—BCL2—asthma	6.22e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	6.22e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—ICAM1—asthma	6.17e-05	0.0014	CbGpPWpGaD
Nepafenac—Angiopathy—Prednisone—asthma	6.15e-05	0.00049	CcSEcCtD
Nepafenac—Immune system disorder—Prednisone—asthma	6.13e-05	0.000487	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—NOS2—asthma	6.12e-05	0.00139	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—asthma	6.11e-05	0.0224	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—asthma	6.07e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	6.07e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—asthma	6.04e-05	0.00137	CbGpPWpGaD
Nepafenac—Nervous system disorder—Methylprednisolone—asthma	5.97e-05	0.000475	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—CD4—asthma	5.95e-05	0.00135	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—asthma	5.94e-05	0.00135	CbGpPWpGaD
Nepafenac—Skin disorder—Methylprednisolone—asthma	5.91e-05	0.00047	CcSEcCtD
Nepafenac—Hypertension—Betamethasone—asthma	5.85e-05	0.000466	CcSEcCtD
Nepafenac—Hypertension—Dexamethasone—asthma	5.85e-05	0.000466	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CHAT—asthma	5.79e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—asthma	5.69e-05	0.00129	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Hydrocortisone—asthma	5.59e-05	0.000445	CcSEcCtD
Nepafenac—Vision blurred—Prednisone—asthma	5.56e-05	0.000443	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—asthma	5.52e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	5.43e-05	0.00123	CbGpPWpGaD
Nepafenac—Nervous system disorder—Dexamethasone—asthma	5.43e-05	0.000432	CcSEcCtD
Nepafenac—Nervous system disorder—Betamethasone—asthma	5.43e-05	0.000432	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—asthma	5.3e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—POMC—asthma	5.26e-05	0.00119	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—asthma	5.16e-05	0.00117	CbGpPWpGaD
Nepafenac—Hypertension—Prednisone—asthma	5.1e-05	0.000406	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.99e-05	0.000397	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—RHOA—asthma	4.97e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LTC4S—asthma	4.96e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CARM1—asthma	4.92e-05	0.00112	CbGpPWpGaD
Nepafenac—Hypersensitivity—Prednisolone—asthma	4.89e-05	0.000389	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—asthma	4.84e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	4.82e-05	0.00109	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—asthma	4.82e-05	0.00109	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Dexamethasone—asthma	4.78e-05	0.00038	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Betamethasone—asthma	4.78e-05	0.00038	CcSEcCtD
Nepafenac—Hypersensitivity—Hydrocortisone—asthma	4.77e-05	0.00038	CcSEcCtD
Nepafenac—Nervous system disorder—Prednisone—asthma	4.73e-05	0.000376	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—asthma	4.7e-05	0.00107	CbGpPWpGaD
Nepafenac—Skin disorder—Prednisone—asthma	4.68e-05	0.000372	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CHAT—asthma	4.59e-05	0.00104	CbGpPWpGaD
Nepafenac—Pruritus—Hydrocortisone—asthma	4.58e-05	0.000365	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—asthma	4.53e-05	0.00103	CbGpPWpGaD
Nepafenac—Hypersensitivity—Triamcinolone—asthma	4.49e-05	0.000358	CcSEcCtD
Nepafenac—Hypersensitivity—Methylprednisolone—asthma	4.48e-05	0.000357	CcSEcCtD
Nepafenac—Dizziness—Prednisolone—asthma	4.38e-05	0.000349	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—asthma	4.37e-05	0.000991	CbGpPWpGaD
Nepafenac—Pruritus—Triamcinolone—asthma	4.31e-05	0.000343	CcSEcCtD
Nepafenac—Pruritus—Methylprednisolone—asthma	4.3e-05	0.000343	CcSEcCtD
Nepafenac—PTGS1—Metabolism—LTA4H—asthma	4.3e-05	0.000977	CbGpPWpGaD
Nepafenac—Dizziness—Hydrocortisone—asthma	4.28e-05	0.000341	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—asthma	4.19e-05	0.000951	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL2—asthma	4.17e-05	0.000948	CbGpPWpGaD
Nepafenac—Headache—Prednisolone—asthma	4.15e-05	0.000331	CcSEcCtD
Nepafenac—Vomiting—Hydrocortisone—asthma	4.12e-05	0.000328	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—asthma	4.09e-05	0.00093	CbGpPWpGaD
Nepafenac—Headache—Hydrocortisone—asthma	4.06e-05	0.000323	CcSEcCtD
Nepafenac—Dizziness—Triamcinolone—asthma	4.03e-05	0.000321	CcSEcCtD
Nepafenac—Dizziness—Methylprednisolone—asthma	4.02e-05	0.00032	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—asthma	3.95e-05	0.000897	CbGpPWpGaD
Nepafenac—Nausea—Prednisolone—asthma	3.94e-05	0.000313	CcSEcCtD
Nepafenac—PTGS2—Metabolism—LTC4S—asthma	3.94e-05	0.000894	CbGpPWpGaD
Nepafenac—Pruritus—Dexamethasone—asthma	3.91e-05	0.000312	CcSEcCtD
Nepafenac—Pruritus—Betamethasone—asthma	3.91e-05	0.000312	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—asthma	3.91e-05	0.000887	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CARM1—asthma	3.91e-05	0.000887	CbGpPWpGaD
Nepafenac—Vomiting—Triamcinolone—asthma	3.88e-05	0.000309	CcSEcCtD
Nepafenac—Vomiting—Methylprednisolone—asthma	3.87e-05	0.000308	CcSEcCtD
Nepafenac—Nausea—Hydrocortisone—asthma	3.85e-05	0.000306	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—asthma	3.84e-05	0.000873	CbGpPWpGaD
Nepafenac—Headache—Triamcinolone—asthma	3.82e-05	0.000304	CcSEcCtD
Nepafenac—Headache—Methylprednisolone—asthma	3.81e-05	0.000303	CcSEcCtD
Nepafenac—PTGS1—Metabolism—ARG1—asthma	3.76e-05	0.000854	CbGpPWpGaD
Nepafenac—Dizziness—Dexamethasone—asthma	3.66e-05	0.000291	CcSEcCtD
Nepafenac—Dizziness—Betamethasone—asthma	3.66e-05	0.000291	CcSEcCtD
Nepafenac—Nausea—Triamcinolone—asthma	3.62e-05	0.000288	CcSEcCtD
Nepafenac—Nausea—Methylprednisolone—asthma	3.61e-05	0.000288	CcSEcCtD
Nepafenac—Hypersensitivity—Prednisone—asthma	3.55e-05	0.000283	CcSEcCtD
Nepafenac—Vomiting—Dexamethasone—asthma	3.52e-05	0.00028	CcSEcCtD
Nepafenac—Vomiting—Betamethasone—asthma	3.52e-05	0.00028	CcSEcCtD
Nepafenac—Headache—Betamethasone—asthma	3.47e-05	0.000276	CcSEcCtD
Nepafenac—Headache—Dexamethasone—asthma	3.47e-05	0.000276	CcSEcCtD
Nepafenac—PTGS2—Metabolism—LTA4H—asthma	3.41e-05	0.000775	CbGpPWpGaD
Nepafenac—Pruritus—Prednisone—asthma	3.41e-05	0.000271	CcSEcCtD
Nepafenac—PTGS1—Metabolism—ALDH7A1—asthma	3.4e-05	0.000772	CbGpPWpGaD
Nepafenac—Nausea—Dexamethasone—asthma	3.29e-05	0.000262	CcSEcCtD
Nepafenac—Nausea—Betamethasone—asthma	3.29e-05	0.000262	CcSEcCtD
Nepafenac—PTGS1—Metabolism—ARG2—asthma	3.26e-05	0.00074	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—asthma	3.26e-05	0.000739	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—asthma	3.22e-05	0.000732	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—EGFR—asthma	3.19e-05	0.000725	CbGpPWpGaD
Nepafenac—Dizziness—Prednisone—asthma	3.19e-05	0.000254	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—asthma	3.1e-05	0.000704	CbGpPWpGaD
Nepafenac—Vomiting—Prednisone—asthma	3.06e-05	0.000244	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—asthma	3.04e-05	0.00069	CbGpPWpGaD
Nepafenac—Headache—Prednisone—asthma	3.02e-05	0.00024	CcSEcCtD
Nepafenac—PTGS2—Metabolism—ARG1—asthma	2.98e-05	0.000678	CbGpPWpGaD
Nepafenac—Nausea—Prednisone—asthma	2.86e-05	0.000228	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.86e-05	0.000649	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX5AP—asthma	2.7e-05	0.000613	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX15—asthma	2.7e-05	0.000613	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH7A1—asthma	2.7e-05	0.000613	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.67e-05	0.000606	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ARG2—asthma	2.59e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CHAT—asthma	2.58e-05	0.000585	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—asthma	2.45e-05	0.000557	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.41e-05	0.000548	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX5—asthma	2.3e-05	0.000521	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.27e-05	0.000515	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.21e-05	0.000503	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CARM1—asthma	2.19e-05	0.000497	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.17e-05	0.000493	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DCN—asthma	2.16e-05	0.00049	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX15—asthma	2.14e-05	0.000487	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX5AP—asthma	2.14e-05	0.000487	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDH2—asthma	2.1e-05	0.000477	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.07e-05	0.000469	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DCN—asthma	2.05e-05	0.000465	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CHAT—asthma	2.05e-05	0.000464	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—asthma	2.02e-05	0.000459	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTT1—asthma	2e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—asthma	1.84e-05	0.000418	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX5—asthma	1.82e-05	0.000414	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CARM1—asthma	1.74e-05	0.000395	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DCN—asthma	1.71e-05	0.000389	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBA—asthma	1.69e-05	0.000383	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH2—asthma	1.67e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NQO1—asthma	1.66e-05	0.000377	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PARP1—asthma	1.65e-05	0.000375	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ADCY2—asthma	1.63e-05	0.000369	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.61e-05	0.000366	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—asthma	1.6e-05	0.000364	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTT1—asthma	1.59e-05	0.00036	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS1—asthma	1.55e-05	0.000352	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ADCY2—asthma	1.54e-05	0.00035	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	1.46e-05	0.000332	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—asthma	1.41e-05	0.000319	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTP1—asthma	1.39e-05	0.000314	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—asthma	1.37e-05	0.00031	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ITPR1—asthma	1.36e-05	0.000309	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—asthma	1.35e-05	0.000306	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NQO1—asthma	1.32e-05	0.000299	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ITPR1—asthma	1.29e-05	0.000293	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ADCY2—asthma	1.29e-05	0.000293	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G4A—asthma	1.27e-05	0.000289	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—asthma	1.27e-05	0.000289	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD86—asthma	1.23e-05	0.000279	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPP2CA—asthma	1.17e-05	0.000266	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SMAD3—asthma	1.16e-05	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.12e-05	0.000253	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP2CA—asthma	1.11e-05	0.000252	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTP1—asthma	1.1e-05	0.00025	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CCR5—asthma	1.09e-05	0.000248	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—asthma	1.08e-05	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ITPR1—asthma	1.08e-05	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—asthma	1.07e-05	0.000243	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDGFB—asthma	1.04e-05	0.000236	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G4A—asthma	1.01e-05	0.000229	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—asthma	1.01e-05	0.000229	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPP2CA—asthma	9.31e-06	0.000211	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—asthma	9.25e-06	0.00021	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—asthma	9e-06	0.000204	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6R—asthma	8.32e-06	0.000189	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—asthma	8.2e-06	0.000186	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—asthma	7.85e-06	0.000178	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—asthma	7.79e-06	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RHOA—asthma	7.51e-06	0.000171	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—asthma	7.44e-06	0.000169	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—asthma	7.18e-06	0.000163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—asthma	7.14e-06	0.000162	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD4—asthma	6.85e-06	0.000156	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—asthma	6.51e-06	0.000148	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTEN—asthma	6.26e-06	0.000142	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—asthma	6.23e-06	0.000141	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PTEN—asthma	5.93e-06	0.000135	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—asthma	5.3e-06	0.00012	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTEN—asthma	4.97e-06	0.000113	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—asthma	4.92e-06	0.000112	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGFR—asthma	4.82e-06	0.000109	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—asthma	3.71e-06	8.41e-05	CbGpPWpGaD
